Uniform Formulary Beneficiary Advisory Panel; Notice of Federal Advisory Committee Meeting, 74999-75000 [2020-25878]

Download as PDF Federal Register / Vol. 85, No. 227 / Tuesday, November 24, 2020 / Notices METZ, DANIELLE A MILLER, BRUCE B MULVIHILL, KEVIN M O’DONNELL, CHRISTOPHER C PAMULAPATI, JAGADEESH ROBERTS, ADARRYL M SALESSES, ROBERT G SCHLEIEN, STEVEN L SWAN, LISA K TINSLEY, ROSALIE WOODDELL WALSH, DANIEL P WARK, LAWRENCE J Dated: November 19, 2020. Aaron T. Siegel, Alternate OSD Federal Register Liaison Officer, Department of Defense. [FR Doc. 2020–25994 Filed 11–23–20; 8:45 am] BILLING CODE 5001–06–P DEPARTMENT OF DEFENSE Reserve Forces Policy Board; Notice of Federal Advisory Committee Meeting Under Secretary of Defense for Personnel and Readiness, Department of Defense (DoD). ACTION: Notice of Federal Advisory Committee meeting. AGENCY: The DoD is publishing this notice to announce that the following Federal Advisory Committee meeting of the Reserve Forces Policy Board (RFPB) will take place. DATES: The RFPB will hold an open to the public meeting on Wednesday, December 9, 2020 from 8:30 a.m. to 12:55 p.m. ADDRESSES: The RFPB meeting will be online using Microsoft Teams CVR and Teleconference line. To participate in the meeting, see the Meeting Accessibility paragraph in the SUPPLEMENTARY INFORMATION section for instructions. FOR FURTHER INFORMATION CONTACT: Alexander Sabol, (703) 681–0577 (Voice), 703–681–0002 (Facsimile), Alexander.J.Sabol.Civ@Mail.Mil (Email). Mailing address is Reserve Forces Policy Board, 5113 Leesburg Pike, Suite 601, Falls Church, VA 22041. Website: https://rfpb.defense.gov/. The most upto-date changes to the meeting agenda can be found on the website and the Federal Register. SUPPLEMENTARY INFORMATION: This meeting is being held under the provisions of the Federal Advisory Committee Act (FACA) (5 U.S.C., Appendix), the Government in the Sunshine Act (5 U.S.C. 552b), and 41 CFR 102–3.140 and 102–3.150. Purpose of the Meeting: The purpose of the meeting is to obtain, review, and jbell on DSKJLSW7X2PROD with NOTICES SUMMARY: VerDate Sep<11>2014 17:48 Nov 23, 2020 Jkt 253001 evaluate information related to strategies, policies, and practices designed to improve and enhance the capabilities, efficiency, and effectiveness of the Reserve Components (RC). Agenda: The RFPB will hold an open online meeting to the public on Wednesday, December 9, 2020 from 8:30 a.m. to 12:55 p.m. The meeting will consist of remarks to the RFPB from the following invited speakers: the Under Secretary of Defense for Personnel and Readiness will discuss the Under Secretary of Defense for Personnel and Readiness’ updates on RC’s personnel system reforms; the Chief of the Air Force Reserve will discuss the priorities and views regarding the Air Force Reserve readiness goals and challenges for the ‘‘Operational Reserve’’ as part of the Total Force; the Commander; the Marine Forces Reserve and Marine Forces North will discuss the priorities and pending changes within the Marine Corps Reserve and their readiness goals and challenges for the ‘‘Operational Reserve’’ as part of the Total Force; the Deputy Assistant of Defense for Military Personnel Policy will brief the status of the Fully Burdened Life Cycle Cost of Manpower Report progress; the RFPB Senior Enlisted Advisor will brief major issues impacting the Total Force as seen by the Reserve Component Senior Enlisted Advisors; and the Subcommittee on Supporting and Sustaining Reserve Component Personnel and the Subcommittee on Ensuring a Ready, Capable, Available, and Sustainable Operational Reserve will provide an update to the RFPB on the subcommittees’ review and proposed recommendation to the Secretary of Defense concerning the Department’s Reserve Personnel’s system and Total Force requirements. Meeting Accessibility: Pursuant to 5 U.S.C. 552b, as amended and 41 CFR 102–3.140 through 102–3.165, and subject to the availability of space, this meeting is open online and teleconference to the public from 8:30 a.m. to 12:55 p.m. Persons desiring to participate in the meeting online or by phone are required to submit their contact information: name, organization, email and telephone to COL Robert D’Alto at robert.r.dalto.mil@mail.mil not later than Friday, December 4, 2020. Specific instructions, both for online or teleconference participation in the meeting, will be provided by reply email. The meeting agenda will be available prior to the meeting on the Board’s website at: https:// rfpb.defense.gov/. Written Statements: Pursuant to section 10(a)(3) of the FACA and 41 CFR PO 00000 Frm 00028 Fmt 4703 Sfmt 4703 74999 102–3.105(j) and 102–3.140, interested persons may submit written statements to the RFPB at any time about its approved agenda or the RFPB’s mission. Written statements should be submitted to the RFPB’s Designated Federal Officer (DFO) at the address, email, or facsimile number listed in the FOR FURTHER INFORMATION CONTACT section. If statements pertain to a specific topic being discussed at the planned meeting, then these statements must be submitted no later than five (5) business days prior to the meeting in question. Written statements received after this date may not be provided to or considered by the RFPB until its next meeting. The DFO will review all timely submitted written statements and provide copies to all the RFPB members before the meeting that is the subject of this notice. Please note that since the RFPB operates in accordance with the provisions of the FACA, all submitted comments and public presentations will be treated as public documents and will be made available for public inspection, including, but not limited to, being posted on the RFPB’s website. Dated: November 18, 2020. Aaron T. Siegel, Alternate OSD Federal Register Liaison Officer, Department of Defense. [FR Doc. 2020–25869 Filed 11–23–20; 8:45 am] BILLING CODE 5001–06–P DEPARTMENT OF DEFENSE Uniform Formulary Beneficiary Advisory Panel; Notice of Federal Advisory Committee Meeting Under Secretary of Defense for Personnel and Readiness, Department of Defense (DoD). ACTION: Notice of Federal Advisory Committee meeting. AGENCY: The DoD is publishing this notice to announce that the following Federal Advisory Committee meeting of the Uniform Formulary Beneficiary Advisory Panel will take place. DATES: Open to the public Thursday, December 17, 2020, from 1:00 p.m. to 3:00 p.m. (Eastern Daylight Time). ADDRESSES: The address of the open meeting will be online. The phone number for the remote access is: CONUS: 888–469–2037; OCONUS: 1– 517–308–9287; PARTICIPANT CODE: 8227323. These numbers and the dial-in instructions will also be posted on the Uniform Formulary Beneficiary Advisory Panel website at: https:// www.health.mil/About-MHS/OASDHA/ Defense-Health-Agency/Operations/ SUMMARY: E:\FR\FM\24NON1.SGM 24NON1 75000 Federal Register / Vol. 85, No. 227 / Tuesday, November 24, 2020 / Notices Pharmacy-Division/BeneficiaryAdvisory-Panel. jbell on DSKJLSW7X2PROD with NOTICES FOR FURTHER INFORMATION CONTACT: Colonel Paul J. Hoerner, USAF, 703– 681–2890 (Voice), dha.ncr.j6.mbx.baprequests@mail.mil (Email). Mailing address is 7700 Arlington Boulevard, Suite 5101, Falls Church, VA 22042–5101. Website: https:// www.health.mil/About-MHS/OASDHA/ Defense-Health-Agency/Operations/ Pharmacy-Division/BeneficiaryAdvisory-Panel. The most up-to-date changes to the meeting agenda can be found on the website. SUPPLEMENTARY INFORMATION: This meeting is being held under the provisions of the Federal Advisory Committee Act (FACA) (5 U.S.C., Appendix), the Government in the Sunshine Act (5 U.S.C. 552b), and 41 CFR 102–3.140 and 102–3.150. The Panel will review and comment on recommendations made to the Director, Defense Health Agency, by the Pharmacy and Therapeutics Committee, regarding the Uniform Formulary. Purpose of the Meeting: The DoD is publishing this notice to announce that the following Federal Advisory Committee meeting of the Uniform Formulary Beneficiary Advisory Panel will take place. Agenda: 1. Sign-In 2. Welcome and Opening Remarks 3. Scheduled Therapeutic Drug Class Reviews a. ADHD Agents—Stimulants b. Respiratory Interleukins—NA 4. Newly Approved Drugs Review 5. Pertinent Utilization Management Issues 6. Panel Discussions and Vote Meeting Accessibility: Pursuant to 5 U.S.C. 552b, and 41 CFR 102–3.140 through 102–3.165, and the subject to availability of phone lines, this meeting open to the public. Seating is limited and will be provided only to the first 220 people dialing in. There will be 220 line total: 200 domestic and 20 international, including leader lines. Written Statements: Pursuant to 41 CFR 102–3.10, and section 10(a)(3) of FACA, interested persons or organizations may submit written statements to the Uniform Formulary Beneficiary Advisory Panel about its mission and/or the agenda to be addressed in this public meeting. Written statements should be submitted to the Uniform Formulary Beneficiary Advisory Panel’s Designated Federal Officer (DFO). The DFO’s contact information can be found in the FOR FURTHER INFORMATION CONTACT section of this notice. Written comments or VerDate Sep<11>2014 17:48 Nov 23, 2020 Jkt 253001 statements must be received by the Uniform Formulary Beneficiary Advisory Panel’s DFO at least four (4) calendar days prior to the meeting so they may be made available to the Uniform Formulary Beneficiary Advisory Panel for its consideration prior to the meeting. The DFO will review all submitted written statements and provide copies to all Uniform Formulary Beneficiary Advisory Panel members. Dated: November 18, 2020. Aaron T. Siegel, Alternate OSD Federal Register Liaison Officer, Department of Defense. [FR Doc. 2020–25878 Filed 11–23–20; 8:45 am] BILLING CODE 5001–06–P DEPARTMENT OF EDUCATION [Docket No.: ED–2020–SCC–0115] Measures and Methods for the National Reporting System for Adult Education; Correction Office of Career, Technical and Adult Education (OCTAE), Department of Education (ED). AGENCY: ACTION: Correction Notice. The PRA Coordinator, Strategic Collections and Clearance, Office of the Chief Data Officer, Office of Planning, Evaluation and Policy Development, hereby issues a correction notice as required by the Paperwork Reduction Act of 1995. SUMMARY: On November 19, 2020, the U.S. Department of Education published a 30-day comment period notice in the Federal Register with FR DOC# 2020– 25550 (Page 73696, Column 1, Column 2) seeking public comment for an information collection entitled, ‘‘Measures and Methods for the National Reporting System for Adult Education’’. The docket number is incorrect. The correct docket number is ED–2020– SCC–0117. SUPPLEMENTARY INFORMATION: Dated: November 19, 2020. Kate Mullan, PRA Coordinator, Strategic Collections and Clearance, Office of the Chief Data Officer, Office of Planning, Evaluation and Policy Development. [FR Doc. 2020–25934 Filed 11–23–20; 8:45 am] BILLING CODE 4000–01–P PO 00000 Frm 00029 Fmt 4703 Sfmt 4703 DEPARTMENT OF EDUCATION [Docket No.: ED–2020–SCC–0178] Agency Information Collection Activities; Submission to the Office of Management and Budget for Review and Approval; Comment Request; Progress in International Reading Literacy Study (PIRLS 2021) Main Study Data Collection Institute of Education Sciences (IES), Department of Education (ED). ACTION: Notice. AGENCY: In accordance with the Paperwork Reduction Act of 1995, ED is proposing a change to a currently existing information collection. DATES: Interested persons are invited to submit comments on or before December 24, 2020. ADDRESSES: Written comments and recommendations for proposed information collection requests should be sent within 30 days of publication of this notice to www.reginfo.gov/public/ do/PRAMain. Find this particular information collection request by selecting ‘‘Department of Education’’ under ‘‘Currently Under Review,’’ then check ‘‘Only Show ICR for Public Comment’’ checkbox. FOR FURTHER INFORMATION CONTACT: For specific questions related to collection activities, please contact Carrie Clarady, 202–245–6347. SUPPLEMENTARY INFORMATION: The Department of Education (ED), in accordance with the Paperwork Reduction Act of 1995 (PRA) (44 U.S.C. 3506(c)(2)(A)), provides the general public and Federal agencies with an opportunity to comment on proposed, revised, and continuing collections of information. This helps the Department assess the impact of its information collection requirements and minimize the public’s reporting burden. It also helps the public understand the Department’s information collection requirements and provide the requested data in the desired format. ED is soliciting comments on the proposed information collection request (ICR) that is described below. The Department of Education is especially interested in public comment addressing the following issues: (1) Is this collection necessary to the proper functions of the Department; (2) will this information be processed and used in a timely manner; (3) is the estimate of burden accurate; (4) how might the Department enhance the quality, utility, and clarity of the information to be collected; and (5) how might the Department minimize the burden of this collection on the SUMMARY: E:\FR\FM\24NON1.SGM 24NON1

Agencies

[Federal Register Volume 85, Number 227 (Tuesday, November 24, 2020)]
[Notices]
[Pages 74999-75000]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-25878]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE


Uniform Formulary Beneficiary Advisory Panel; Notice of Federal 
Advisory Committee Meeting

AGENCY: Under Secretary of Defense for Personnel and Readiness, 
Department of Defense (DoD).

ACTION: Notice of Federal Advisory Committee meeting.

-----------------------------------------------------------------------

SUMMARY:  The DoD is publishing this notice to announce that the 
following Federal Advisory Committee meeting of the Uniform Formulary 
Beneficiary Advisory Panel will take place.

DATES:  Open to the public Thursday, December 17, 2020, from 1:00 p.m. 
to 3:00 p.m. (Eastern Daylight Time).

ADDRESSES:  The address of the open meeting will be online. The phone 
number for the remote access is: CONUS: 888-469-2037; OCONUS: 1-517-
308-9287; PARTICIPANT CODE: 8227323. These numbers and the dial-in 
instructions will also be posted on the Uniform Formulary Beneficiary 
Advisory Panel website at: https://www.health.mil/About-MHS/OASDHA/
Defense-Health-Agency/Operations/

[[Page 75000]]

Pharmacy-Division/Beneficiary-Advisory-Panel.

FOR FURTHER INFORMATION CONTACT:  Colonel Paul J. Hoerner, USAF, 703-
681-2890 (Voice), [email protected] (Email). Mailing 
address is 7700 Arlington Boulevard, Suite 5101, Falls Church, VA 
22042-5101. Website: https://www.health.mil/About-MHS/OASDHA/Defense-Health-Agency/Operations/Pharmacy-Division/Beneficiary-Advisory-Panel. 
The most up-to-date changes to the meeting agenda can be found on the 
website.

SUPPLEMENTARY INFORMATION:  This meeting is being held under the 
provisions of the Federal Advisory Committee Act (FACA) (5 U.S.C., 
Appendix), the Government in the Sunshine Act (5 U.S.C. 552b), and 41 
CFR 102-3.140 and 102-3.150.
    The Panel will review and comment on recommendations made to the 
Director, Defense Health Agency, by the Pharmacy and Therapeutics 
Committee, regarding the Uniform Formulary.
    Purpose of the Meeting: The DoD is publishing this notice to 
announce that the following Federal Advisory Committee meeting of the 
Uniform Formulary Beneficiary Advisory Panel will take place.
    Agenda:

1. Sign-In
2. Welcome and Opening Remarks
3. Scheduled Therapeutic Drug Class Reviews
    a. ADHD Agents--Stimulants
    b. Respiratory Interleukins--NA
4. Newly Approved Drugs Review
5. Pertinent Utilization Management Issues
6. Panel Discussions and Vote

    Meeting Accessibility: Pursuant to 5 U.S.C. 552b, and 41 CFR 102-
3.140 through 102-3.165, and the subject to availability of phone 
lines, this meeting open to the public. Seating is limited and will be 
provided only to the first 220 people dialing in. There will be 220 
line total: 200 domestic and 20 international, including leader lines.
    Written Statements: Pursuant to 41 CFR 102-3.10, and section 
10(a)(3) of FACA, interested persons or organizations may submit 
written statements to the Uniform Formulary Beneficiary Advisory Panel 
about its mission and/or the agenda to be addressed in this public 
meeting. Written statements should be submitted to the Uniform 
Formulary Beneficiary Advisory Panel's Designated Federal Officer 
(DFO). The DFO's contact information can be found in the FOR FURTHER 
INFORMATION CONTACT section of this notice. Written comments or 
statements must be received by the Uniform Formulary Beneficiary 
Advisory Panel's DFO at least four (4) calendar days prior to the 
meeting so they may be made available to the Uniform Formulary 
Beneficiary Advisory Panel for its consideration prior to the meeting. 
The DFO will review all submitted written statements and provide copies 
to all Uniform Formulary Beneficiary Advisory Panel members.

    Dated: November 18, 2020.
Aaron T. Siegel,
Alternate OSD Federal Register Liaison Officer, Department of Defense.
[FR Doc. 2020-25878 Filed 11-23-20; 8:45 am]
BILLING CODE 5001-06-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.